Last edition
News about "Dexamethasone Otic Suspension"
Alembic Pharma Gets US FDA Final Approval for Otic Suspension
Alembic Pharmaceuticals receives US FDA final approval for generic ciprofloxacin and dexamethasone otic suspension, targeting specified ear infections. The product’s US market is valued at USD 110 million.
Dexamethasone Otic Suspension | 19/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members